The Limitations of Clinical Mais for Prevention of IDDM

Mahon, Jeffrey L; Dupre, John

doi:10.2337/diacare.20.6.1027

Article navigation

Commentary| June 01 1997

The Limitations of Clinical Mais for Prevention of IDDM

Jeffrey L Mahon, MD, MSC, FRCPC;

Jeffrey L Mahon, MD, MSC, FRCPC

Department of Medicine, Department of Physiology, University of Western Ontario

London, Ontario, Canada

Department of Epidemiology and Biostatistics, University of Western Ontario

London, Ontario, Canada

Search for other works by this author on:

This Site

PubMed

Google Scholar

John Dupre, MA, FRCPC, FRCP, FACP

Department of Medicine, Department of Physiology, University of Western Ontario

London, Ontario, Canada

Department of Epidemiology and Biostatistics, University of Western Ontario

London, Ontario, Canada

Search for other works by this author on:

This Site

PubMed

Google Scholar

Address correspondence and reprint requests to Jeffrey Mahon, MD, Room 6 OF-11, University Hospital, P.O. Box 5339, 339 Windermere Rd., London, Ontario N6A 5A5, Canada. E-mail: [email protected]

Diabetes Care 1997;20(6):1027–1033

https://doi.org/10.2337/diacare.20.6.1027

PubMed:

9167119

The Limitations of Clinical Mais for Prevention of IDDM

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

The Limitations of Clinical Mais for Prevention of IDDM Free

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only

The Limitations of Clinical Mais for Prevention of IDDM